A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Citicoline (Primary) ; Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 07 Nov 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Nov 2017.
- 07 Nov 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 25 Jul 2016 New trial record